Transcriptomics

Dataset Information

0

Effects of HIF2α in renal cancer metastasis and sensitivity to repurposed drugs


ABSTRACT: Background: in clear cell renal cell carcinoma (ccRCC), 80% of cases have biallelic inactivation of VHL gene, leading to constitutive activation of both HIF1α and HIF2α. As HIF2α is the driver of the disease promoting tumour growth and metastasis, drugs targeting HIF2α have been developed. However, resistance is common, therefore new therapies are needed. Methods: we generated the 786-0 HIF2α knockout (KO) cell line and assessed the HIF2α antagonist PT2385 in several steps of tumour development. RNA sequencing was performed to identify genes differentially expressed between them and a drug screening was used to identify drugs with differential effects on HIF2α-expressing and KO cells. Results: HIF2α KO promoted cell migration, reduced proliferation and clonogenicity, as well as metastasis, whereas PT2385 treatment only inhibited tumour cell invasion. There was a large set of co-ordinately regulated genes, but HIF2α KO cells also had up-regulation of genes related to EMT and downregulation of genes involving cell migration and extracellular matrix. The HIF2α KO increased sensitivity to statins, while PT2385 had no effect. Conclusions: this study shows new pathways that could be targeted combined with PT2385 to enhance its therapeutic effects and delay resistance.

ORGANISM(S): Homo sapiens

PROVIDER: GSE153711 | GEO | 2021/08/11

REPOSITORIES: GEO

Similar Datasets

| PRJNA643786 | ENA
2020-06-04 | GSE151703 | GEO
2023-12-11 | GSE249461 | GEO
2014-09-18 | E-GEOD-50941 | biostudies-arrayexpress
2014-05-01 | GSE54898 | GEO
2020-11-24 | GSE142719 | GEO
2017-08-23 | GSE102994 | GEO
2014-09-18 | GSE51081 | GEO
2014-09-18 | GSE50941 | GEO